Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation

被引:4
作者
Ma, Ying-Qian [1 ,2 ]
Zhang, Ming [1 ,5 ]
Sun, Zhen-Hua [1 ]
Tang, Hong-Yue [3 ]
Wang, Ying [2 ]
Liu, Jiang-Xue [2 ]
Zhang, Zhan-Xue [4 ]
Wang, Chao [3 ]
机构
[1] Hebei Gen Hosp, Dept Oncol, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Sch Grad Studies, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Gen Hosp, Clin Med Res Ctr, Shijiazhuang 050051, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 2, Dept Gastrointestinal Surg, Shijiazhuang 050000, Hebei, Peoples R China
[5] Hebei Gen Hosp, Dept Oncol, 348 Heping West Rd, Shijiazhuang 050051, Hebei, Peoples R China
关键词
Resveratrol; Gastric cancer; Network pharmacology; Bioinformatics; Molecular docking; CELL-CYCLE; C-FOS; PROLIFERATION; INHIBITORS; PROTEIN;
D O I
10.4251/wjgo.v16.i2.493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Gastric cancer (GC) is one of the most aggressive malignancies with limited therapeutic options and a poor prognosis. Resveratrol, a non-flavonoid polyphenolic compound found in a variety of Chinese medicinal materials, has shown excellent anti-GC effect. However, its exact mechanisms of action in GC have not been clarified. AIM To identify the effects of resveratrol on GC progression and explore the related molecular mechanisms. METHODS Action targets of resveratrol and GC-related targets were screened from public databases. The overlapping targets between the two were confirmed using a Venn diagram, and a "Resveratrol-Target-GC" network was constructed using Cytoscape software version 3.9.1. The protein-protein interaction (PPI) network was constructed using STRING database and core targets were identified by PPI network analysis. The Database for Annotation, Visualization and Integrated Discovery database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A "Target-Pathway" network was created by using Cytoscape 3.9.1. The RNA and protein expression levels of core target genes were observed using the Cancer Genome Atlas and the Human Protein Atlas databases. DriverDBv3 and Timer2.0 databases were used for survival and immune infiltration analysis. Subsequently, the findings were further verified by molecular docking technology and in vitro experiments. RESULTS A total of 378 resveratrol action targets and 2154 GC disease targets were obtained from public databases, and 181 intersection targets between the two were screened by Venn diagram. The top 20 core targets were identified by PPI network analysis of the overlapping targets. GO function analysis mainly involved protein binding, identical protein binding, cytoplasm, nucleus, negative regulation of apoptotic process and response to xenobiotic stimulus. KEGG enrichment analysis suggested that the involved signaling pathways mainly included PI3K-AKT signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, ErbB signaling pathway, etc. FBJ murine osteosarcoma viral oncogene homolog (FOS) and matrix metallopeptidase 9 (MMP9) were selected by differential expression analysis, and they were closely associated with immune infiltration. Molecular docking results showed that resveratrol docked well with these two targets. Resveratrol treatment arrested the cell cycle at the S phase, induced apoptosis, and weakened viability, migration and invasion in a dose-dependent manner. Furthermore, resveratrol could exhibit anti-GC effect by regulating FOS and MMP9 expression. CONCLUSION The anti-GC effects of resveratrol are related to the inhibition of cell proliferation, migration, invasion and induction of cell cycle arrest and apoptosis by targeting FOS and MMP9.
引用
收藏
页码:493 / 513
页数:22
相关论文
共 50 条
  • [31] Unveiling Isorhapontigenin’s therapeutic potential in lung cancer via integrated network pharmacology, molecular docking, and experimental validation
    Zhiyu Wu
    Chengyu Hou
    Qiulin Zhu
    Zixia Huang
    Zesheng Lu
    Chunhui Shen
    Zhenhui Wang
    Yanzhong Liu
    Yanfen Kang
    JiYong Wang
    Scientific Reports, 15 (1)
  • [32] Network pharmacology study and in vitro experimental validation of Xiaojianzhong decoction against gastric cancer
    Chen, Guo-Qing
    Nan, Yi
    Ning, Na
    Huang, Shi-Cong
    Bai, Yu-Ting
    Zhou, Zi-Ying
    Qian, Gu
    Li, Wei-Qiang
    Yuan, Ling
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (09) : 3932 - 3954
  • [33] Network pharmacology, bioinformatics, and experimental validation to identify the role of Hedyotis diffusa willd against gastric cancer through the activation of the endoplasmic reticulum stress
    Ou, Ling
    Li, Mengyang
    Hou, Yan
    HELIYON, 2024, 10 (07)
  • [34] Network pharmacology-based identification of the antitumor effects of taraxasterol in gastric cancer
    Chen, Wei
    Li, Jingwei
    Li, Chen
    Fan, Hui-Ning
    Zhang, Jing
    Zhu, Jin-Shui
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2020, 34
  • [35] An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer
    Wang, Ziyuan
    Zhang, Zhipeng
    Azami, Nisma Lena Bahaji
    Hui, Dengcheng
    Wang, Zheng
    Xie, Dong
    Ye, Guan
    Liu, Ningning
    Sun, Mingyu
    JOURNAL OF MEDICINAL FOOD, 2024, 27 (12) : 1168 - 1182
  • [36] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Zhang, Yan
    Qi, Yifei
    Jia, Zijun
    Li, Yiming
    Wu, Liqi
    Zhou, Qingbing
    Xu, Fengqin
    CHINESE MEDICINE, 2024, 19 (01)
  • [37] The Molecular Mechanisms of Bergapten Against Abdominal Aortic Aneurysm: Evidence From Network Pharmacology, Molecular Docking/Dynamics, and Experimental Validation
    Xu, Fujia
    Luo, Sihan
    Huang, Zhenhua
    Wang, Junfen
    Li, Tian
    Zhong, Lintao
    Si, Xiaoyun
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2025, 126 (04)
  • [38] Exploring the Targets and Molecular Mechanisms of Thalidomide in the Treatment of Ulcerative Colitis: Network Pharmacology and Experimental Validation
    Li, Jun
    Tao, Qin
    Xie, Yang
    Wang, Peng
    Jin, Ruiri
    Huang, Xia
    Chen, Youxiang
    Zeng, Chunyan
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (34) : 2721 - 2737
  • [39] Integrated network pharmacology, molecular docking and experimental validation to investigate the mechanism of tannic acid in nasopharyngeal cancer
    Wang, Meiwei
    He, Longmei
    Yan, Pan
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [40] Identifying the Mechanisms of Rosa Roxburghii Tratt on Treating Gastric Cancer: Combining the Targetable Screening From the Cancer Genome Atlas With Network Pharmacology
    Tang, Li
    Zhang, Shuo
    Ji, Jia-Cheng
    Wang, Peng-Jiao
    Zhang, Min
    Feng, Pei-Mei
    Gao, Xiu-Li
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (11)